A Surgically Treated Long-term Survivor of Hepatocellular Carcinoma with Tumor Thrombi in the Trunk of the Portal Vein

Hiroshima Journal of Medical Sciences

Volumn 47, Issue 4, 1998, Pages 157-161

  Asahara, Toshimasa ^a   Itamoto, Toshiyuki ^a   Katayama, Koji ^a   Nakahara, Hideki ^a   Okamoto, Yuzo ^a   Hino, Hiroshi ^a   Ono, Eiji ^a   Dohi, Kiyohiko ^a   Shimamoto, Fumio ^b  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatic resection; Hepatocellular carcinoma; Tumor thrombectomy; Tumor thrombi

Indexed keywords

ANTINEOPLASTIC AGENT; IODINATED POPPYSEED OIL;

ARTICLE; CASE REPORT; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PORTAL VEIN; THROMBOSIS; TIME;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MIDDLE AGED; PORTAL VEIN; THROMBOSIS; TIME FACTORS;

EID: 0032250220     PISSN: 00182052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ando, E., Yamashita, F., Tanaka, M. and Tanikawa, K. 1997. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer 79: 1890-1896.
2. Bismuth, H., Marino, M., Sherlock, D., Castaing, D., Miglietta, C., Cauquil, P. and Roche, A. 1992. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am. J. Surg. 163: 387-394.
3. Edmondson, H. A. and Steiner, P. E. 1954. Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 7: 462-503.
4. Itamoto, T., Asahara, T., Okamoto, Y., Ochi, M., Nakahara, H., Katayama, K. and Dohi, K. 1993. Experimental and clinical study on in situ liver cold perfusion. Jpn. J. Phleobol. 4: 93-102 (in Japanese).
5. Hamazaki, K., Mimura, H., Miyashima, T., Gouichi, A., Orita, K., Irisawa, M. and Hiraki, Y. 1990. A case of necrosis of hepatocellular carcinoma and tumor thrombus in the portal vein induced by transcatheter arterial lipiodol chemoembolization. Acta Med. Okayama 44: 155-159.
6. Kumada, K., Ozawa, K., Okamoto, R., Takayasu, T., Yamaguchi, M., Yamamoto, Y., Higashiyama, H., Morikawa, S., Sasaki, H., Shimahara, Y., Yamaoka, Y. and Takeuchi, E. 1990. Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi. Surgery 108: 821-827.
7. Lee, H. S., Kim, J. S., Choi, I. J., Chung, J. W., Park, J. H. and Kim, C. Y. 1997. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 79: 2087-2093.
8. Okazaki, M., Higashihara, H. and Shijo, H. 1997. Chemoembolization, p. 307-326. In T. Livraghi, M. Makuuchi and L. Buscarini (eds.), Diagnosis and treatment of hepatocellular carcinoma. Greenwich Medical Media, London.
9. Okuda K. 1986. Early recognition of hepatocellular carcinoma. Hepatology 4: 729-738.
10. Pugh, R.N.H., Murray-Lyon, I.M., Dawson, J.L., Pietroni, M.C. and Williams, R. 1973.Transection of oesophagus for bleeding varices. Br. J. Surg. 60: 646-649.
11. Sitzmann, J. V. and Abram, R. 1993. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann. Surg. 217: 149-154.
12. Tanaka, A., Morimoto, T., Ozaki, N., Ikai, I., Yamamoto, Y., Tsunekawa, S., Kitai, T. and Yamaoka, Y. 1996. Extension of surgical indication for advanced hepatocellular carcinoma: Is it possible to prolong life span or improve quality of life? Hepatogastroenterol. 43: 1172-1181.
13. Takada, K., Nakamura, K., Manabe, T., Usuki, N., Kaminou, T., Yamada, T., Takashima, S., Nakatsuka, H., Minakuchi, K. and Onoyama, Y. 1992. Transcatheter therapy for hepatocellular carcinoma with tumor thrombi in the main branch of the portal vein or inferior vena cava. Acta Hepatolo. Jpn. 33: 531-540 (in Japanese).
14. The Liver Cancer Study Group of Japan. 1992. The general rules for the clinical and pathological study of primary liver cancer. 3rd ed. Kanehara Shuppan Co,. Tokyo.
15. The Liver Cancer Study Group of Japan. 1987. Primary liver cancer in Japan. Cancer 60: 1400-1411.
16. The Liver Cancer Study Group of Japan. 1990. Primary liver cancer in Japan: Clinicopathological features and results of surgical treatment. Ann. Surg. 211: 277-287.
17. The Liver Cancer Study Group of Japan. 1994. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 74: 2772-2780.
18. Urata, K., Matsumata, T., Kamakura, T., Hasuo, K. and Sugimachi, K. 1994. Lipiodolization for unresectable hepatocellular carcinoma: An analysis of 205 patients using univariate and multivariate analysis. J. Surg. Oncol. 56: 54-58.
19. Yamada, R., Sato, M., Kawabata, M., Nakatsuka, H., Nakamura, K. and Takashima, S. 1983. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148: 397-401.